76 related articles for article (PubMed ID: 32315421)
1. Response to: Eosinophil count in severe coronavirus disease 2019.
Qian GQ; Zhang X; Ma AHY; Yang NB
QJM; 2020 Jul; 113(7):513-514. PubMed ID: 32315421
[No Abstract] [Full Text] [Related]
2. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.
Perlini S; Ciprandi G; Castagnoli R; Licari A; Marseglia GL
Allergy Asthma Proc; 2020 Nov; 41(6):e80-e82. PubMed ID: 33109314
[No Abstract] [Full Text] [Related]
3. [Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19].
Li YX; Wu W; Yang T; Zhou W; Fu YM; Feng QM; Ye JM
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):372-374. PubMed ID: 32370466
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].
Ding YQ; Bian XW
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):291-293. PubMed ID: 32268662
[TBL] [Abstract][Full Text] [Related]
5. [Determination Methods of 2019 Novel Coronavirus (SARS-CoV-2)].
Pan X; Yao Y; Cao C; Huang Y; Wu J
Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Apr; 44(4):359-362. PubMed ID: 32762214
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).
Foldes D; Hinton R; Arami S; Bain BJ
Am J Hematol; 2020 Jul; 95(7):861-862. PubMed ID: 32298486
[No Abstract] [Full Text] [Related]
7. [DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)].
Otto-Knapp R; Häcker B; Breuer C; Diel R; Kaufmann SHE; Korr G; Pfeiffer M; Schaberg T; Schönfeld N; Witte P; Bauer T
Pneumologie; 2020 Jul; 74(7):412-416. PubMed ID: 32674189
[No Abstract] [Full Text] [Related]
8. Rhabdomyolysis as Potential Late Complication Associated with COVID-19.
Chan KH; Slim J
Emerg Infect Dis; 2020 Oct; 26(10):2535. PubMed ID: 32614765
[No Abstract] [Full Text] [Related]
9. A hundred days into the coronavirus disease (COVID-19) pandemic.
Steffens I
Euro Surveill; 2020 Apr; 25(14):. PubMed ID: 32290905
[No Abstract] [Full Text] [Related]
10. Treatments for COVID-19: emerging drugs against the coronavirus.
Khademolhosseini S; Kavandi H; Ghaffari S
Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921740
[TBL] [Abstract][Full Text] [Related]
11. Treatments for COVID-19: emerging drugs against the coronavirus - reply.
Potì F
Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921741
[No Abstract] [Full Text] [Related]
12. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.
Bonow RO; Fonarow GC; O'Gara PT; Yancy CW
JAMA Cardiol; 2020 Jul; 5(7):751-753. PubMed ID: 32219362
[No Abstract] [Full Text] [Related]
13. The Impact of COVID-19 on Italy: A Lesson for the Future.
Santacroce L; Bottalico L; Charitos IA
Int J Occup Environ Med; 2020 Jul; 11(3):151-152. PubMed ID: 32225178
[No Abstract] [Full Text] [Related]
14. Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree. Comment on "A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis".
Forster P; Forster L
JMIR Public Health Surveill; 2020 Nov; 6(4):e23542. PubMed ID: 33174859
[No Abstract] [Full Text] [Related]
15. Management of Patients With Severe Mental Illness During the Coronavirus Disease 2019 Pandemic.
Kahl KG; Correll CU
JAMA Psychiatry; 2020 Sep; 77(9):977-978. PubMed ID: 32579183
[No Abstract] [Full Text] [Related]
16. Antibody Profiles in Mild and Severe Cases of COVID-19.
Liu ZL; Liu Y; Wan LG; Xiang TX; Le AP; Liu P; Peiris M; Poon LLM; Zhang W
Clin Chem; 2020 Aug; 66(8):1102-1104. PubMed ID: 32521002
[No Abstract] [Full Text] [Related]
17. [COVID-19-never waste a crisis?!].
Herold CJ; Delorme S; Weber MA; Reith W; Helmberger T; Reiser M
Radiologe; 2020 Oct; 60(10):891-892. PubMed ID: 32995967
[No Abstract] [Full Text] [Related]
18. Myocardial injury in severe COVID-19 infection.
Jaffe AS; Cleland JGF; Katus HA
Eur Heart J; 2020 Jun; 41(22):2080-2082. PubMed ID: 32464642
[No Abstract] [Full Text] [Related]
19. Exposure to SARS-CoV-2 in a high transmission setting increases the risk of severe COVID-19 compared with exposure to a low transmission setting?
Chen D; Hu C; Su F; Song Q; Wang Z
J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32502262
[No Abstract] [Full Text] [Related]
20. Reply to "Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care".
Ather A; Patel B; Ruparel NB; Diogenes A; Hargreaves KM
J Endod; 2020 Sep; 46(9):1342. PubMed ID: 32810475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
